ERBB2 and cancer: Stratifying tumors by their subtype, a significant difference of VISTA-positive TILs expression was observed between HER2-positive and triple-negative tumors (p = 0.0138; Figure 7A), with no differences in VISTA-positive cancer cells (p = 0.4677; Figure 7B).